1. Home
  2. Clinical Topics
  3. FDA allows marketing of cooling cap for chemotherapy
Clinical TopicsDrugs and DevicesOncologyWeb Exclusives

FDA allows marketing of cooling cap for chemotherapy


On Dec. 8, the U.S. Food and Drug Administration (FDA) cleared the Dignitana DigniCap Cooling System for marketing. The system reduces the frequency and severity of alopecia during chemotherapy in breast cancer patients. Read more.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts